Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38.

PubMed  PubMed Central  Article  Google Scholar 

Caligiuri ME, Perrotta P, Augimeri A, Rocca F, Quattrone A, Cherubini A. Automatic detection of white matter hyperintensities in healthy aging and pathology using magnetic resollauce knagmg: a review. Neuromformatics. 2015;13:261–76.

Article  Google Scholar 

Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E. Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology. 2014;82:2127–38.

PubMed  Article  Google Scholar 

Hainsworth AH, Minett T, Andoh J, Forster G, Bhide I, Barrick TR, et al. Neuropathology of white matter lesions, blood-brain barrier dysfunction, and dementia. Stroke. 2017;48:2799–804.

PubMed  PubMed Central  Article  Google Scholar 

Coutu JP, Goldblatt A, Rosas HD, Salat DH. Alzheimer’s Disease Neuroimaging Initiative (ADNI). White matter changes are associated with ventricular expansion in aging, mild cognitive impairment, and Alzheimer’S disease. J Alzheimers Dis. 2016;49:329–42.

PubMed  PubMed Central  Article  Google Scholar 

Wang L, Leonards CO, Sterzer P, Ebinger M. White matter lesions and depression: a systematic review and meta-analysis. J Psychiatr Res. 2014;56:56–64.

PubMed  Article  Google Scholar 

Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821–5.

PubMed  Article  Google Scholar 

Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.

PubMed  Article  Google Scholar 

Wolfson L, Wakefield DB, Moscufo N, Kaplan RF, Hall CB, Schmidt JA, et al. Rapid buildup of brain white matter hyperintensities over 4 years linked toambulatory blood pressure, mobility, cognition, and depression in old persons. J Gerontol A Biol Sci Med Sci. 2013;68:1387–94.

PubMed  PubMed Central  Article  Google Scholar 

Guevarra AC, Ng SC, Saffari SE, Wong BYX, Chander RJ, Ng KP, et al. Age moderates associations of hypertension, white matter hyperintensities, and cognition. J Alzheimers Dis. 2020;75:1351–60.

PubMed  Article  Google Scholar 

Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, et al. White matterhyperintensities and imaging patterns of brain ageing in the general population. Brain. 2016;139:1164–79.

PubMed  PubMed Central  Article  Google Scholar 

Abraham HM, Wolfson L, Moscufo N, Guttmann CR, Kaplan RF, White WB. Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons. J Cereb Blood Flow Metab. 2016;36:132–42.

PubMed  PubMed Central  Article  Google Scholar 

Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, et al. Midlife hypertention and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol. 2014;21287:1–10.

Google Scholar 

Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation. 2011;123:266–73.

PubMed  Article  Google Scholar 

Wang DQ, Wang L, Wei MM, Xia XS, Tian XL, Cui XH, et al. Relationship between type 2 diabetes and white matter hyperintensity: a systematic review. Front Endocrinol. 2020;11:595962.

Article  Google Scholar 

Rist PM, Buring JE, Rexrode KM, Cook NR, Rost NS. Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients. Eur J Epidemiol. 2019;34:957–65.

PubMed  PubMed Central  Article  Google Scholar 

Andreescu C, Tudorascu D, Sheu LK, Rangarajan A, Butters MA, Walker S, et al. Brain structural changes in late-life generalized anxiety disorder. Psychiatry Res Neuroimaging. 2017;268:15–21.

PubMed  Article  Google Scholar 

Karcher HS, Holzwarth R, Mueller HP, Ludolph AC, Huber R, Kassubek J, et al. Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study. Cerebrovasc Dis. 2013;35:341–8.

PubMed  Article  Google Scholar 

Smith AD, Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36:211–39.

CAS  PubMed  Article  Google Scholar 

Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr. 2019;6:49.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131:362–9.

CAS  PubMed  Article  Google Scholar 

Wang CY, Chen ZW, Zhang T, Liu J, Chen SH, Liu SY, et al. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertension patients. Eur J Intern Med. 2014;25:538–44.

CAS  PubMed  Article  Google Scholar 

Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, et al. Vascular disease and risk factors are associated with cognitive decline in the Alzheimer disease spectrum. Alzheimer Dis Assoc Disord. 2019;29:18–25.

Article  Google Scholar 

Nelson ME, Andel R, Nedelska Z, Martinkova J, Cechova K, Markova H, et al. The association between homocysteine and memory in older adults. J Alzheimer Dis. 2021;81:413–26.

CAS  Article  Google Scholar 

Smith AD, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A, et al. Homocysteine and dementia: an international consensus statement. J Alzheimers Dis. 2018;62:561–70.

PubMed  PubMed Central  Article  Google Scholar 

Tu W, Yan F, Chao B, Ji X, Wang L. Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018. Front Med. 2021;15:903–12.

PubMed  Article  Google Scholar 

Zhao W, Gao F, Lv L, Chen X. The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States. J Hypertens. 2022;40:254–63.

Shokouhi M, Qiu D, Samman Tahhan A, Quyyumi AA, Hajjar I. Differential Associations of diastolic and systolic pressures with cerebral measures in older individuals with mild cognitive impairment. Am J Hypertens. 2018;31:1268–77.

PubMed  PubMed Central  Article  Google Scholar 

Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, et al. Midlife hypertention and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol. 2014;21287:1–10.

Google Scholar 

Li M, Fu B, Dong W. Correlations between plasma homocysteine and MTHFR gene polymorphism and white matter lesions. Folia Neuropathol. 2018;56:301–7.

PubMed  Article  Google Scholar 

Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354:407–13. 31

CAS  PubMed  Article  Google Scholar 

Katsiki N, Perez-Martinez P, Mikhailidis DP. Homocysteine and non-cardiac vascular disease. Curr Pharm Des. 2017;23:3224–32.

CAS  PubMed  Google Scholar 

Khan U, Crossley C, Kalra L, Rudd A, Wolfe CD, Collinson P, et al. Homocysteine and its relationship to stroke subtypes in a UK black population: the South London Ethnicity and Stroke Study. Stroke. 2008;39:2943–9.

CAS  PubMed  Article  Google Scholar 

Linnebank M, Moskau S, Jürgens A, Simon M, Semmler A, Orlopp K, et al. Association of genetic variants of methionine metabolism with methotrexate‐induced CNS white matter changes in patients with primary CNS lymphoma. Neuro Oncol. 2009;11:2–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hong ED, Taylor WD, McQuoid DR, Potter GG, Payne ME, Ashley‐Koch A, et al. Influence of the MTHFR C677T polymorphism on magnetic resonance imaging hyperintensity volume and cognition in geriatric depression. Am J Geriatr Psychiatry. 2009;17:847–55.

PubMed  PubMed Central  Article  Google Scholar 

Cuadrado-Godia E, Dwivedi P, Sharma S, Ois Santiago A, Roquer Gonzalez J, Balcells M, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. J Stroke. 2018;20:302–20.

PubMed  PubMed Central  Article  Google Scholar 

Moretti R, Caruso P. The controversial role of homocysteine in neurology: from labs to clinical practice. Int J Mol Sci. 2019;20:231.

PubMed Central  Article  CAS  Google Scholar 

Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131:362–9.

CAS  PubMed  Article  Google Scholar 

Pang X, Liu J, Zhao J, Mao J, Zhang X, Feng L, et al. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-KB signal pathway in rat vascular smooth muscle cells. Atherosclerosis. 2014;236:73–81.

CAS  PubMed  Article  Google Scholar 

Ma Y, Zhao X, Zhang W, Liu L, Wang Y, Fang R, et al. Homocysteine and ischemic stroke subtype: a relationship study in Chinese patients. Neurol Res. 2010;32:636–41.

CAS  PubMed  Article  Google Scholar 

Feng C, Bai X, Xu Y, Hua T, Huang J, Liu XY. Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease. Int J Med Sci. 2013;10:408–12.

PubMed  PubMed Central  Article